News and events bulletin

events@enterprise.cam.ac.uk
December 2010

Cambridge inventions and portfolio companies in the news

Cambridge spin-outs named as finalists for European entrepreneurship awards

The next generation of motion sensors
The incredible shrinking circuit
Cambridge Challenge Fund marks ten years
Sphere Fluidics receives Royal Society funding
Horizon’s cell-models predict that a subset of cancers respond to EGFR therapy
CamSemi appoints new chairman and new CFO
Breathing Buildings technology adopted by Asda
Q-Flo signs deal to continue development of ‘elastic smoke’
Enval completes Life Cycle Analysis research project for Unilever
Cambridge researchers receive Royal Society awards
Camfridge joins European consortium on energy efficiency

Cambridge Enterprise announces 2010 results

Income generated from the University of Cambridge’s commercialisation

activities continued to rise in 2010, as did the number of intellectual property
and consultancy agreements signed on behalf of the University’s researchers.

Responsible for the commercialisation of University research, Cambridge

Enterprise recently announced its results for the 2010 financial year. Income
from licensing, consultancy and equity realisations in 2010 was £8.4 million, of
which £6.6 million was or will be distributed to academics and departments.
Over the past three years, income has exceeded £27 million, with over £22
million of that amount being returned to University researchers and
departments.

Cambridge Enterprise currently provides support to close to 1,000 University researchers at all stages of
the commercialisation process, from supporting grant proposals, to licensing technology to existing
companies, through to funding new companies and ventures. Read more

Follow us on Twitter for updates on the Discovery

Fund, Cambridge Enterprise Seed Funds and our
portfolio companies.
Taking control of medical imaging Licensing opportunities

A new controller device that greatly A selection of some of the latest

improves the ease of use of 3D medical licensing opportunities available
imaging workstations has been developed through Cambridge Enterprise:
at the University of Cambridge and
Addenbrooke’s Hospital. Macrolide antibiotic as an
antiviral agent ● Novel
The device was presented at RSNA2010, homeostatic peptides ● Insect
the annual meeting of the Radiological resistant surfaces ● Improved
Society of North America, which was held ultrasound imaging techniques
last month in Chicago. Additionally, a short ● Methods to induce
film describing the controller is available on differentiation of embryonic
the University’s YouTube site, www.youtube.com/ stem cells ● Cell culture model
cambridgeuniversity. for Huntingdon’s Disease ●
Novel bacteriophage resistance
The huge growth in three-dimensional medical imaging technology in system ● Predicting auto-
recent years means that radiologists are now routinely examining immune disease progression ●
complex 3D data image sets. Increasingly, they are using 2D image Novel marker for cancer
planes that slice through this data at a variety of angles to obtain the diagnosis ● Transgenic mouse
most clinically informative view. Read more model for immunological studies
● Efficient nonlinear optical
Forthcoming events of interest
chromophores ● Coating of
nanoscale arrays ● Apparatus
for ultra-low volume fluid
Enterprise Tuesday sensing ● Electrolytic production
Department of Engineering of carbon nanotubes ●
Improved thyristor device ●
Enterprise Tuesday is a series of free evening lectures and
networking sessions managed and delivered by the Centre for Click here for further details on
Entrepreneurial Learning since 1999. The programme aims to these and more licensing
introduce participants to the world of business, as well as to opportunities.
encourage and inspire individuals to pursue their entrepreneurial
ambition. It is the most popular non-assessed programme within the Research Reagents
University and the model has been adopted by numerous other
academic institutions as well as corporations. Antibodies, cell lines, proteins,
DNA constructs, plasmids and
The Lent Term lectures begin on 18 January and run each week until other reagents generated by
22 February. researchers are the foundation
for much biological research. A
For more information, or to book a place, click here. selection of research reagents is
available here. Alternatively,
please contact us directly with
your specific requirements.
Understanding Finance for Business
Enterprise Network
St John’s Innovation Centre, Cambridge
The University Enterprise
Are you fundraising or preparing to raise your next round? If so, the
Network (UEN) helps support
‘Understanding Finance for Business’ programme, including
the flow of information to
workshops, mentoring and pitch coaching, could provide the support
students and staff about the
you need. The programme is delivered by a team of experienced and
wide range of entrepreneurship
highly connected entrepreneurs, investors and advisors based at St
and innovation activities
John’s Innovation Centre in Cambridge.
available to help raise
awareness, develop skills and
For more information, or to book a place at this event, click here.
provide direct advice and
support.